{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:41:39Z","timestamp":1758588099399,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.transproceed.2018.02.016","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T21:06:44Z","timestamp":1523653604000},"page":"723-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intravenous Immunoglobulin and Rituximab in HLA Highly Sensitized Kidney Transplant Recipients"],"prefix":"10.1016","volume":"50","author":[{"given":"S.","family":"Querido","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Weigert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Adrag\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Birne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Matias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bruges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2018.02.016_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.TP.0000109643.32659.C4","article-title":"Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials","volume":"77","author":"Webster","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.02.016_bib2","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1681\/ASN.V8111771","article-title":"Effect of anti-lymphocyte induction therapy on renal allograft survival: a meta-analysis","volume":"8","author":"Szczech","year":"1997","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2018.02.016_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1034\/j.1399-0012.2000.140306.x","article-title":"Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants","volume":"14","author":"Barama","year":"2000","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2018.02.016_bib4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/eji.1830160802","article-title":"Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes","volume":"16","author":"Tedder","year":"1986","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.transproceed.2018.02.016_bib5","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/j.1600-6143.2006.01497.x","article-title":"Pharmacodynamics of rituximab in kidney allotransplantation","volume":"6","author":"Genberg","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.02.016_bib6","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/TP.0b013e3181a27683","article-title":"Reconstitution of peripheral allospecific CD19+ B-cell subsets after B-lymphocyte depletion therapy in renal transplant patients","volume":"87","author":"Kopchaliiska","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.02.016_bib7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ctrv.2005.05.007","article-title":"Tolerability and safety of rituximab (MabThera)","volume":"31","author":"Kimby","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.transproceed.2018.02.016_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1517\/14712598.2012.646984","article-title":"Update on the role of rituximab in kidney diseases and transplant","volume":"12","author":"Ramanath","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.transproceed.2018.02.016_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/tri.12072","article-title":"Rituximab in renal transplantation","volume":"26","author":"Barnett","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2018.02.016_bib10","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/TP.0000000000000362","article-title":"A\u00a0systematic review of the use of rituximab for desensitization in renal transplantation","volume":"98","author":"Macklin","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.02.016_bib11","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00262-011-1168-2","article-title":"Rituximab-induced direct inhibition of T-cell activation","volume":"61","author":"Stroopinsky","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.transproceed.2018.02.016_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ajt.13052","article-title":"Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety","volume":"15","author":"van den Hoogen","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.02.016_bib13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-128-10-199805150-00004","article-title":"The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data. Anti-Lymphocyte Antibody Induction Therapy Study Group","volume":"128","author":"Szczech","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2018.02.016_bib14","first-page":"45","article-title":"The current trend of induction and maintenance treatment in patient of different PRA levels: a report on OPTN\/UNOS Kidney Transplant Registry data","author":"Cai","year":"2010","journal-title":"Clin Transpl"},{"key":"10.1016\/j.transproceed.2018.02.016_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1399-0012.2005.00275.x","article-title":"A\u00a0prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipients","volume":"19","author":"Zaltzman","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2018.02.016_bib16","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1111\/j.1399-0012.2010.01306.x","article-title":"The effect of HLA mismatch on highly sensitized renal allograft recipients","volume":"24","author":"Paramesh","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2018.02.016_bib17","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1600-6143.2005.01178.x","article-title":"A\u00a0comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody","volume":"6","author":"Stegall","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.02.016_bib18","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1600-6143.2004.00507.x","article-title":"Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy","volume":"4","author":"Sonnenday","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.02.016_bib19","doi-asserted-by":"crossref","first-page":"E450","DOI":"10.1111\/ctr.12021","article-title":"The role of Thymoglobulin induction in kidney transplantation: an update","volume":"26","author":"Mourad","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2018.02.016_bib20","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1600-6143.2004.00454.x","article-title":"Rituximab as treatment for refractory kidney transplant rejection","volume":"4","author":"Becker","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.02.016_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.smim.2011.08.019","article-title":"B\u00a0cells in clinical transplantation tolerance","volume":"24","author":"Adams","year":"2012","journal-title":"Semin Immunol"},{"key":"10.1016\/j.transproceed.2018.02.016_bib22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.20344\/amp.4959","article-title":"Urinary tract infections in a cohort of kidney transplant recipients","volume":"27","author":"Bispo","year":"2014","journal-title":"Acta Med Port"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518300721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518300721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:30:39Z","timestamp":1758576639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518300721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0041134518300721"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.02.016","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Immunoglobulin and Rituximab in HLA Highly Sensitized Kidney Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}